This package includes 15.75 contact hours (which expire on 3/3/2026).
Sessions Included:
Conference Welcome // Urological Considerations in the Management of the Gender-Diverse Patient Following Gender-Affirming Surgery (Mar 01, 2024 01:30 PM)
Urogenital Fistulas (Mar 01, 2024 03:25 PM)
Pharmacologic Management of Peyronie’s Disease and Ejaculatory Disorders (Mar 01, 2024 03:25 PM)
Training the Advanced Practice Provider in Urology (Mar 02, 2024 08:00 AM)
Nocturia (Mar 02, 2024 10:50 AM)
Urogynecology and Reconstructive Pelvic Surgery (URPS) (Mar 02, 2024 11:55 AM)
Product Theater Lunch - Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment - Sponsored by Sumitomo (Mar 02, 2024 01:00 PM)
Screening Guidelines for Early Detection of Prostate Cancer (Mar 02, 2024 02:20 PM)
Multidisciplinary and Trauma-Informed Care Strategies for Interstitial Cystitis and Pelvic Pain (Mar 02, 2024 03:30 PM)
Sonographic Evaluation of the Pelvic Floor (Mar 02, 2024 04:35 PM)
Product Theater Breakfast - A Treatment Approach for Certain Patients with High-risk, Non-muscle Invasive Bladder Cancer - Sponsored by Merck (Mar 03, 2024 07:00 AM)
Why Federal Advocacy Matters for the Nursing Profession (Mar 03, 2024 08:25 AM)
Anabolic Steroid-Induced Hypogonadism (Mar 03, 2024 09:35 AM)
Pessaries (Mar 03, 2024 09:35 AM)
Telehealth Nursing: Pre & Post Pandemic (Mar 03, 2024 10:45 AM)
Product Theater Lunch - Go Further. Help Get To the Root Cause of Early-Onset or Recurrent Kidney Stone Disease with novoDETECT - Sponsored by Novo Nordisk (Mar 03, 2024 11:45 AM)
Navigating the AI Landscape: Essential Applications for Advanced Practice Nursing (Mar 03, 2024 01:00 PM)
Bridging the Healthcare Divide: APPs at the Forefront of Expanding Access to Quality Care Nationwide // Closing Remarks (Mar 03, 2024 02:10 PM)
After content is purchased, CH is available for: $15 per session
CH expire on 3/3/2026.
Sessions Included:
Conference Welcome // Urological Considerations in the Management of the Gender-Diverse Patient Following Gender-Affirming Surgery (Mar 01, 2024 01:30 PM)
Urogenital Fistulas (Mar 01, 2024 03:25 PM)
Pharmacologic Management of Peyronie’s Disease and Ejaculatory Disorders (Mar 01, 2024 03:25 PM)
Training the Advanced Practice Provider in Urology (Mar 02, 2024 08:00 AM)
Nocturia (Mar 02, 2024 10:50 AM)
Urogynecology and Reconstructive Pelvic Surgery (URPS) (Mar 02, 2024 11:55 AM)
Product Theater Lunch - Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment - Sponsored by Sumitomo (Mar 02, 2024 01:00 PM)
Screening Guidelines for Early Detection of Prostate Cancer (Mar 02, 2024 02:20 PM)
Multidisciplinary and Trauma-Informed Care Strategies for Interstitial Cystitis and Pelvic Pain (Mar 02, 2024 03:30 PM)
Sonographic Evaluation of the Pelvic Floor (Mar 02, 2024 04:35 PM)
Product Theater Breakfast - A Treatment Approach for Certain Patients with High-risk, Non-muscle Invasive Bladder Cancer - Sponsored by Merck (Mar 03, 2024 07:00 AM)
Why Federal Advocacy Matters for the Nursing Profession (Mar 03, 2024 08:25 AM)
Anabolic Steroid-Induced Hypogonadism (Mar 03, 2024 09:35 AM)
Pessaries (Mar 03, 2024 09:35 AM)
Telehealth Nursing: Pre & Post Pandemic (Mar 03, 2024 10:45 AM)
Product Theater Lunch - Go Further. Help Get To the Root Cause of Early-Onset or Recurrent Kidney Stone Disease with novoDETECT - Sponsored by Novo Nordisk (Mar 03, 2024 11:45 AM)
Navigating the AI Landscape: Essential Applications for Advanced Practice Nursing (Mar 03, 2024 01:00 PM)
Bridging the Healthcare Divide: APPs at the Forefront of Expanding Access to Quality Care Nationwide // Closing Remarks (Mar 03, 2024 02:10 PM)